Trasylol Not Associated With Renal/Heart Failure, MI, Stroke, Cmte. Says

FDA’s Cardiovascular & Renal Drugs Advisory Committee reiterate risk of renal dysfunction associated with aprotinin at its Sept. 21 meeting.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet